{"id":"https://openalex.org/W3096926340","doi":"https://doi.org/10.1182/blood-2020-137801","title":"Resource Utilization and Factors Prolonging Hospitalization for Patients with Relapsed and Refractory Large B-Cell Lymphoma Receiving Tisagenlecleucel Versus Axicabtagene Ciloleucel","display_name":"Resource Utilization and Factors Prolonging Hospitalization for Patients with Relapsed and Refractory Large B-Cell Lymphoma Receiving Tisagenlecleucel Versus Axicabtagene Ciloleucel","publication_year":2020,"publication_date":"2020-11-05","ids":{"openalex":"https://openalex.org/W3096926340","doi":"https://doi.org/10.1182/blood-2020-137801","mag":"3096926340"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2020-137801","doi":"https://doi.org/10.1182/blood-2020-137801","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-137801","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081036608","display_name":"Agrima Mian","orcid":"https://orcid.org/0000-0001-6992-4883","observed_orcids":["https://orcid.org/0000-0001-6992-4883"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Agrima Mian","raw_affiliation_strings":["Department of Internal Medicine, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100323732","display_name":"Wei Wei","orcid":"https://orcid.org/0000-0002-6244-3187","observed_orcids":["https://orcid.org/0000-0002-6244-3187","https://orcid.org/0000-0002-3117-9598"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wei Wei","raw_affiliation_strings":["Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006235077","display_name":"Brian Thomas Hill","orcid":"https://orcid.org/0000-0001-8781-3327","observed_orcids":["https://orcid.org/0000-0001-8781-3327"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian T. Hill","raw_affiliation_strings":["Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050880000","display_name":"Betty K. Hamilton","orcid":"https://orcid.org/0000-0003-1252-6539","observed_orcids":["https://orcid.org/0000-0003-1252-6539"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Betty K. Hamilton","raw_affiliation_strings":["Department of Hematology and Medical Oncology, Leukemia Program, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Medical Oncology, Leukemia Program, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009726852","display_name":"Allison Marie Winter","orcid":"https://orcid.org/0000-0002-8437-7539","observed_orcids":["https://orcid.org/0000-0002-8437-7539"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Allison M. Winter","raw_affiliation_strings":["Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001877903","display_name":"Jack Khouri","orcid":"https://orcid.org/0000-0002-2473-6528","observed_orcids":["https://orcid.org/0000-0002-2473-6528"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jack Khouri","raw_affiliation_strings":["Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013767912","display_name":"Brad L. Pohlman","orcid":"https://orcid.org/0000-0001-6006-3714","observed_orcids":["https://orcid.org/0000-0001-6006-3714"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brad Pohlman","raw_affiliation_strings":["Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013162117","display_name":"Deepa Jagadeesh","orcid":"https://orcid.org/0000-0002-1772-0659","observed_orcids":["https://orcid.org/0000-0002-1772-0659"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Deepa Jagadeesh","raw_affiliation_strings":["Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110947084","display_name":"Alex Garcia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alex V. Mejia Garcia","raw_affiliation_strings":["Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005991606","display_name":"Faiz Anwer","orcid":"https://orcid.org/0000-0001-6914-7439","observed_orcids":["https://orcid.org/0000-0001-6914-7439"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Faiz Anwer","raw_affiliation_strings":["Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023728016","display_name":"Aaron Thomas Gerds","orcid":"https://orcid.org/0000-0002-3422-1309","observed_orcids":["https://orcid.org/0000-0002-3422-1309"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron T. Gerds","raw_affiliation_strings":["Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112129467","display_name":"Matt E Kalaycio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matt Kalaycio","raw_affiliation_strings":["Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011431831","display_name":"Robert M. Dean","orcid":"https://orcid.org/0000-0003-2559-563X","observed_orcids":["https://orcid.org/0000-0003-2559-563X"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert M. Dean","raw_affiliation_strings":["Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011655907","display_name":"Ronald M. Sobecks","orcid":"https://orcid.org/0000-0003-1608-3261","observed_orcids":["https://orcid.org/0000-0003-1608-3261"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ronald Sobecks","raw_affiliation_strings":["Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5019494133","display_name":"Navneet S. Majhail","orcid":"https://orcid.org/0000-0001-7082-891X","observed_orcids":["https://orcid.org/0000-0001-7082-891X"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Navneet S. Majhail","raw_affiliation_strings":["Department of Hematology and Medical Oncology, Leukemia Program, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Medical Oncology, Leukemia Program, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1316902750"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.2008,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.51958351,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":95},"biblio":{"volume":"136","issue":"Supplement 1","first_page":"38","last_page":"39"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10693","display_name":"Blood transfusion and management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.8410000205039978},{"id":"https://openalex.org/keywords/tisagenlecleucel","display_name":"tisagenlecleucel","score":0.9929999709129333},{"id":"https://openalex.org/keywords/axicabtagene-ciloleucel","display_name":"axicabtagene ciloleucel","score":1.0},{"id":"https://openalex.org/keywords/length-of-hospital-stay","display_name":"length of hospital stay","score":0.671999990940094},{"id":"https://openalex.org/keywords/resource-utilization-health-care","display_name":"resource utilization (health care)","score":0.7080000042915344},{"id":"https://openalex.org/keywords/days-alive-and-out-of-hospital","display_name":"days alive and out of hospital","score":0.9120000004768372},{"id":"https://openalex.org/keywords/hospital-readmission","display_name":"hospital readmission","score":0.574999988079071},{"id":"https://openalex.org/keywords/outpatient-visits","display_name":"outpatient visits","score":0.39500001072883606},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.335999995470047},{"id":"https://openalex.org/keywords/treatment-related-adverse-events","display_name":"treatment-related adverse events","score":0.35499998927116394}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8849453926086426},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.4745396375656128},{"id":"https://openalex.org/C2777371436","wikidata":"https://www.wikidata.org/wiki/Q3237071","display_name":"Leukapheresis","level":4,"score":0.4519517123699188},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.44700291752815247},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4415074586868286},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.08506986498832703},{"id":"https://openalex.org/C10205521","wikidata":"https://www.wikidata.org/wiki/Q4035578","display_name":"CD34","level":3,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2020-137801","doi":"https://doi.org/10.1182/blood-2020-137801","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2020-137801","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3001726414","https://openalex.org/W3127311168","https://openalex.org/W7127363202","https://openalex.org/W4285606063","https://openalex.org/W4224030133","https://openalex.org/W3213053919","https://openalex.org/W4391265244","https://openalex.org/W4283723340","https://openalex.org/W3001823821","https://openalex.org/W3171055065"],"abstract_inverted_index":{"Introduction":[0],"Use":[1],"of":[2,68,75,128,150,165,173,222,233,285,302,310,345,350,356,364,526,557,566,588,599,612,642,652,662,678,758,775],"the":[3,64,126,171,380,595],"two":[4],"commercially":[5],"available":[6],"anti":[7],"CD19":[8],"chimeric":[9],"antigen":[10],"receptor":[11],"T-cell":[12,180,601],"(CAR":[13],"T-cell)":[14],"therapies":[15,590],"in":[16,201,206,422,665,682],"patients":[17,78,194,212,238,276,295,377,436,473,513,605],"with":[18,29,79,83,195,219,277,292,437,514,533,538,546,578,633],"relapsed":[19],"and":[20,32,50,55,112,117,154,184,188,204,227,256,268,318,336,367,400,412,425,453,476,536,551,617,625,645,650,667],"refractory":[21],"(R/R)":[22],"large":[23],"B-cell":[24],"lymphoma":[25],"(LBCL)":[26],"is":[27,673],"associated":[28],"significant":[30],"inpatient":[31,100],"outpatient":[33,103,311],"resource":[34,143,668],"utilization,":[35,144,669],"which":[36,136],"has":[37],"not":[38,576],"been":[39],"systematically":[40],"compared.":[41],"We":[42,71],"characterized":[43],"institutional":[44,142],"resources":[45],"used":[46,200],"around":[47],"Tisagenlecleucel":[48],"(tisa-cel)":[49],"Axicabtagene":[51],"ciloleucel":[52],"(axi-cel)":[53],"infusion":[54,181],"identified":[56],"factors":[57],"that":[58,131],"led":[59],"to":[60,93,158,376,432,441,455,498,580,630,675],"longer":[61,494,542],"hospitalization":[62,286],"during":[63],"first":[65,162,596],"100":[66,163,177,324,597],"days":[67,130,155,164,304,355,363,393,598,615,624],"therapy.":[69,166,234],"Methods":[70],"reviewed":[72],"medical":[73],"records":[74],"consecutive":[76],"adult":[77],"R/R":[80,196,603],"LBCL":[81,604],"treated":[82,632],"tisa-cel":[84,187,205,267,381,438,492,607,637,681],"or":[85,254,519,586,655,760,777],"axi-cel":[86,189,198,269,272,501,679],"at":[87,119],"our":[88],"center":[89],"from":[90,170],"May":[91,94],"2018":[92],"2020.":[95],"Resource":[96],"utilization":[97],"data":[98],"included":[99],"hospital":[101,386,610],"days,":[102,291,530],"clinic":[104,312],"visits,":[105,313],"radiological":[106],"studies,":[107,109,315],"cardiac/neurologic":[108,316],"invasive":[110,319],"procedures":[111,321],"pharmaceutical":[113],"resources.":[114],"\"Days":[115],"alive":[116,616],"out-of-hospital":[118],"Day":[120,176,323,469],"100\"":[121],"(DAOH100),":[122],"were":[123,168,213,217,264,325,420,485,510],"defined":[124],"as":[125,138,145],"number":[127,309,587],"living":[129],"a":[132,139,300,343,670,704],"patient":[133,684],"spent":[134],"out-of-hospital,":[135,618],"served":[137],"surrogate":[140],"for":[141,148,299,512],"it":[146],"accounted":[147],"duration":[149,284],"index":[151],"hospitalization,":[152],"re-admissions":[153],"lost":[156],"due":[157],"premature":[159],"death,":[160],"within":[161],"Data":[167],"collected":[169],"day":[172],"leukapheresis":[174],"through":[175,322],"post":[178],"CAR":[179,600],"(day":[182],"0),":[183],"compared":[185,375,497,629],"between":[186],"recipients.":[190],"Results":[191],"Of":[192],"46":[193],"LBCL,":[197],"was":[199,287],"35":[202,423],"(76%)":[203,424],"11":[207],"(24%)":[208],"patients.":[209],"30":[210],"(65%)":[211],"male,":[214],"44":[215],"(96%)":[216],"Caucasian,":[218],"median":[220,301,308,344,483,495,565],"age":[221],"61":[223],"(range,":[224,229,289,305,327,330,334,338,347,353,360,369,487],"25-77)":[225],"years":[226],"3":[228,303],"2-6)":[230],"prior":[231,278,589],"lines":[232],"Forty-":[235],"one":[236],"(89%)":[237],"had":[239,245,250,259,383,439,474,479,541,608],"stage":[240],"III/IV":[241],"disease,":[242],"24":[243],"(52%)":[244],"IPI":[246,585],"0-2,":[247],"36":[248],"(78%)":[249],"ECOG":[251,516,648],"PS":[252,517,649],"0":[253,337,352],"1":[255,333,346],"29":[257],"(63%)":[258],"HCT-CI":[260],"<3.":[261],"Baseline":[262],"characteristics":[263],"comparable":[265],"among":[266],"recipients,":[270],"except":[271],"group":[273,382],"having":[274],"more":[275,614],"autologous":[279],"transplant":[280],"(Table":[281,406,466,507,591],"1).":[282],"Median":[283],"14":[288],"7-53)":[290],"13":[293],"(28%)":[294],"requiring":[296],"ICU":[297],"admission":[298],"1-19).":[306],"The":[307,482],"radiology":[314],"evaluations":[317],"diagnostic":[320],"5":[326],"0-11),":[328],"6":[329],"1-":[331],"31),":[332],"0-33)":[335],"0-5),":[339],"respectively.":[340,429,573],"Patients":[341,490,532,635],"required":[342],"0-4)":[348],"dose(s)":[349],"tocilizumab,":[351],"0-14)":[354],"IV":[357,365,391],"steroids,":[358],"7":[359,368],"0-":[361],"54)":[362],"antibiotics":[366],"0-60)":[370],"blood":[371,402,626],"product":[372,403,627],"transfusions.":[373],"When":[374],"receiving":[378,491,500,606,636],"axi-cel,":[379,433],"significantly":[384,434,657],"shorter":[385,390,609],"stay":[387],"(P=":[388,394],"0.02),":[389],"steroid":[392,623],"0.006),":[395],"fewer":[396,401,435,620],"tocilizumab":[397,621],"doses":[398],"(P=0.04)":[399],"transfusions":[404],"(P=0.0004)":[405],"2).":[407,467,508],"Cytokine":[408],"release":[409],"syndrome":[410,418],"(CRS)":[411],"immune":[413],"effector":[414],"cell":[415],"mediated":[416],"neurotoxicity":[417],"(ICANS)":[419],"seen":[421],"23":[426],"(50%)":[427],"patients,":[428],"In":[430,660],"comparison":[431],"moderate":[440,454],"severe":[442,456],"(\u2265":[443,457,523],"Grade":[444,458,548,553],"2)":[445,459,524],"CRS":[446,550,644,654],"(18.18":[447],"%":[448],"vs.":[449,462,503,521,544,559,568,680],"60%;":[450],"P=":[451,464,505,562,571],"0.04),":[452],"ICANS":[460,555,656],"(0%":[461],"37.14%;":[463],"0.02)":[465],"By":[468],"100,":[470],"15":[471],"(32.6%)":[472],"died":[475],"4":[477],"(10.8%)":[478],"disease":[480],"progression.":[481],"DAOH100":[484,496,509,543,574],"86":[486],"0-93)":[488],"days.":[489],"experienced":[493,639],"those":[499,537,545,631],"(89":[502],"86;":[504],"0.01)":[506],"higher":[511],"favorable":[515],"(0":[518],"1)":[520],"unfavorable":[522],"(median":[525,556],"87":[527,558,567],"vs":[528],"73":[529],"P=0.01).":[531],"no/mild":[534,539],"CRS,":[535],"ICANS,":[540],"\u2265":[547,552],"2":[549,554],"84":[560],"days;":[561,570],"0.047":[563],"&":[564],"70":[569],"0.01),":[572],"did":[575],"differ":[577],"respect":[579],"age,":[581],"gender,":[582],"stage,":[583],"HCT-CI,":[584],"3).":[592],"Conclusion":[593],"Through":[594],"therapy,":[602],"length":[611],"stay,":[613],"received":[619],"doses,":[622],"transfusions,":[628],"axi-cel.":[634],"also":[638],"lesser":[640],"incidence":[641],"moderate/severe":[643,653],"ICANS.":[646],"Favorable":[647],"absence":[651],"increased":[658],"DAOH100.":[659],"light":[661],"these":[663],"differences":[664],"toxicity":[666],"future":[671],"study":[672],"needed":[674],"compare":[676],"efficacy":[677],"larger":[683],"cohorts.":[685],"Disclosures":[686],"Hill:":[687],"Genentech:":[688],"Consultancy,":[689,694,699,707,712,715,720,728,733,738,744,806,814,823],"Honoraria,":[690,695,700,708,716,721,729,734,739,799],"Research":[691,696,701,709,717,722,725,730,735,740,763,767,781,785,800,807,810,815,824,828,832,836,839],"Funding;":[692,697,702,710,718,723,726,731,736,764,768,782,808,811,816,825,829,833,837],"Beigene:":[693],"AstraZenica:":[698],"Kite,":[703],"Gilead":[705,826],"Company:":[706],"Novartis:":[711],"Honoraria;":[713,842,848],"BMS:":[714],"Celgene:":[719,822],"Takeda:":[724],"Karyopharm:":[727],"Pharmacyclics:":[732],"Abbvie:":[737],"Funding.":[741,786,840],"Hamilton:Syndax":[742],"Pharmaceuticals:":[743],"Honoraria.":[745,850],"Khouri:Sanofi":[746],"Genzyme:":[747],"Other:":[748],"Advisory":[749],"Board.":[750],"Jagadeesh:Seattle":[751],"Genetics:":[752],"Membership":[753,770],"on":[754,771],"an":[755,772],"entity's":[756,773],"Board":[757,774],"Directors":[759,776],"advisory":[761,778],"committees,":[762],"Debiopharm":[765],"Group:":[766],"Verastem:":[769],"committees;":[779],"Regeneron:":[780],"MEI":[783],"Pharma:":[784],"Anwer:Incyte,":[787],"Seattle":[788],"Genetics,":[789],"Acetylon":[790],"Pharmaceuticals,":[791],"AbbVie":[792],"Pharma,":[793,795],"Astellas":[794],"Celegene,":[796],"Millennium":[797],"Pharmaceuticals.:":[798],"Funding,":[801],"Speakers":[802],"Bureau.":[803],"Gerds:CTI":[804],"Biopharma:":[805],"Roche/Genentech:":[809],"Incyte":[812],"Corporation:":[813],"AstraZeneca/MedImmune:":[817],"Consultancy;":[818,821,845],"Apexx":[819],"Oncology:":[820,835],"Sciences:":[827],"Imago":[830],"Biosciences:":[831],"Sierra":[834],"Pfizer:":[838],"Majhail:Mallinckrodt:":[841],"Anthem,":[843],"Inc.:":[844],"Nkarta":[846],"Therapeutics:":[847],"Incyte:":[849]},"counts_by_year":[{"year":2022,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2020-11-09T00:00:00"}